Budesolv

  • Budesolv 1
  • Budesolv 2
Product Description

novel preservative-free budesonide nasal spray, IP protected formulation

Read more Show less

Marinomed Biotech AG

  • AT
  • 2020
    On CPHI since
  • 25 - 49
    Employees
Company types
Biopharmaceutical company
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Biopharmaceutical
Contract Research Organisation
Laboratory Services
Medical Devices
Pharmaceutical Company (innovator finished products)
View company profile
Categories
more categories Show less
Specifications
  • Model
    nasal spray
More specifications Fewer specifications
Sales Markets
Show more Show less

Marinomed Biotech AG

  • AT
  • 2020
    On CPHI since
  • 25 - 49
    Employees
Company types
Biopharmaceutical company
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Biopharmaceutical
Contract Research Organisation
Laboratory Services
Medical Devices
Pharmaceutical Company (innovator finished products)
View company profile

More Products from Marinomed Biotech AG (1)

  • Solv4U

    Product Solv4U

    Poor water solubility of drug candidates is one of the most common hurdles pharmaceutical development is confronted with. Promising new chemical entities and drug candidates often fail in development due to the limitations of their solubility in water.

    Marinomed Biotech AG provides Solv4U techno...

Marinomed Biotech AG resources (1)

  • Marinosolv® - A Novel Approach to Increase the Solubility and Improve the Bioavailability of Promising Low-Soluble Drugs

    Whitepaper Marinosolv® - A Novel Approach to Increase the Solubility and Improve the Bioavailability of Promising Low-Soluble Drugs

    80-90% of promising, highly potent drug candidates in the R&D pipeline fail due to their low solubility in aqueous formulations, and subsequently their low bioavailability.The solubility of a drug in aqueous formulations is a critical factor for the permeability and thereby bioavailability and systemic absorption into sensitive target tissues and/or at the site of action. Therefore, several different chemical and physical approaches to increase the solubility of a drug in aqueous formulations have become available in the last decade. One of them is Marinosolv®, a formulation technology that provides effective solubilization for a variety of highly hydrophobic small molecules and peptides, including APIs/NCEs.